[Correspondence] Colistin versus colistin plus meropenem for severe infections

In their randomised controlled superiority trial, Mical Paul and colleagues1 found that the addition of meropenem to colistin did not improve clinical failure in patients with severe Acinetobacter baumannii infections. The study brings important high-level evidence to the discussion on the use of combination therapies against multidrug-resistant Gram negatives.2
Source: The Lancet Infectious Diseases - Category: Infectious Diseases Authors: Tags: Correspondence Source Type: research